MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
ENDRA Life Sciences Operating Expenses 2011-2026 | NDRA
Annual Operating Expenses ENDRA Life Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.8 M | 10.5 M | 13.2 M | 11.5 M | - | 10.8 M | 8.74 M | 4.8 M | 2.07 M | 2.31 M | 1.83 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.2 M | 1.83 M | 7.66 M |
Quarterly Operating Expenses ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.37 M | 1.3 M | 1.47 M | - | 1.51 M | 2.23 M | 2.78 M | - | 3.13 M | 2.99 M | 2.94 M | - | 3.42 M | 3.57 M | 2.86 M | - | 2.65 M | 3.2 M | 2.58 M | - | 3.26 M | 2.89 M | 3.1 M | - | 2.64 M | 2.33 M | 2.75 M | - | 2.36 M | 1.82 M | 2.84 M | - | 1.08 M | 1.06 M | 361 K | - | 605 K | 494 K | 373 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.57 M | 361 K | 2.2 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
29.2 M | $ 19.11 | 0.47 % | $ 99.4 M |  Israel |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Co-Diagnostics
CODX
|
45.3 M | $ 5.31 | 4.89 % | $ 156 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
726 M | $ 20.49 | -2.36 % | $ 215 M |  China |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 38.74 | -0.41 % | $ 1.08 B | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
6.71 B | $ 228.43 | -0.21 % | $ 167 B | USA |
 |
DexCom
DXCM
|
1.69 B | $ 66.86 | 0.74 % | $ 25.8 B | USA |
 |
BioNano Genomics
BNGO
|
41.3 M | $ 1.56 | 1.96 % | $ 1.98 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
DarioHealth Corp.
DRIO
|
62.2 M | $ 11.42 | 0.35 % | $ 324 M | Israel |
 |
IQVIA Holdings
IQV
|
2.94 B | $ 225.43 | 0.01 % | $ 40.9 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.79 | 0.23 % | $ 18.9 B | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 25.95 | -1.24 % | $ 785 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
CareDx, Inc
CDNA
|
484 M | $ 19.2 | 1.91 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
113 M | $ 100.08 | 0.34 % | $ 3.95 B | USA |
 |
Anixa Biosciences
ANIX
|
9.98 M | $ 3.09 | -0.96 % | $ 98.6 K | USA |
 |
Myriad Genetics
MYGN
|
709 M | $ 6.22 | 1.14 % | $ 564 M | USA |
 |
NeoGenomics
NEO
|
382 M | $ 11.76 | - | $ 1.49 B | USA |
 |
Guardant Health
GH
|
226 M | $ 101.08 | -1.04 % | $ 12.4 B | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 18.42 | -1.89 % | $ 452 M | USA |
 |
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
OPKO Health
OPK
|
217 M | $ 1.26 | 0.4 % | $ 874 M | USA |
 |
Precipio
PRPO
|
13.6 M | $ 24.92 | 8.46 % | $ 32.3 M | USA |
 |
Personalis
PSNL
|
44.5 M | $ 7.76 | -2.52 % | $ 460 M | USA |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Illumina
ILMN
|
3.69 B | $ 132.27 | 0.85 % | $ 21 B | USA |
 |
Charles River Laboratories International
CRL
|
607 M | $ 200.24 | 0.38 % | $ 10.3 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 172.79 | -0.43 % | $ 19.2 B | USA |
|
Biodesix
BDSX
|
106 M | $ 6.84 | 0.51 % | $ 887 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.14 | 0.22 % | $ 20 B |  Niderland |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 250.12 | -0.3 % | $ 21 B | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 186.86 | 2.55 % | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.25 B | $ 666.09 | -1.54 % | $ 54.9 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 66.89 | 0.51 % | $ 4.63 B | USA |
 |
Mettler-Toledo International
MTD
|
1.01 B | $ 1 395.51 | 0.09 % | $ 29.6 B |  Schweiz |
 |
Agilent Technologies
A
|
1.99 B | $ 136.02 | -0.04 % | $ 41.4 B | USA |